PharmaGuidePress & Media
Everything a journalist needs, in one place.
Boilerplate descriptions, leadership facts, brand assets, and the press contact. If you're writing about PharmaGuide and need something we haven't included, email us with your topic and deadline.
Press contact · press@pharmaguide.io
Quick facts
The numbers and the names.
- Founded
- 2025
- Headquarters
- Boston, MA · USA
- Founder & CEO
- Sean Cheick Baradji
- Parent company
- B&Br Technology
- Label source
- NIH DSLD · 200,000+ labels
- Beta testing
- Small group, including clinicians
- Access
- Opening in small groups
- Categories
- Health · Medical · Lifestyle
Boilerplate
Three lengths. Pick what you need.
One-liner
PharmaGuide helps people understand supplement product information and interaction warnings, with core stack checks running on-device.
One paragraph
PharmaGuide brings supplement product information, known interaction warnings and stack checks into one app. Its catalog uses label information from NIH's Dietary Supplement Label Database, a source containing 200,000+ labels; that is not a count of products evaluated by PharmaGuide. A small group, including clinicians, is testing the app as beta access opens gradually. Core stack checks run on-device. Medications, conditions and health profiles stay on the device by default, with an explicit, scoped option to share with an AI assistant. FDA recall alerts are in development and are not available in the current beta. Founded 2025 in Boston by Sean Cheick Baradji.
Longer description
PharmaGuide helps people connect supplement product information with their medications and existing stack. Current checks can surface known interaction warnings, overlapping nutrients and medication and nutrient links. Results depend on the available product data and the details entered. Where a product can be evaluated, the PG Score out of 100 covers six dimensions: formulation, dose, evidence, transparency, verification, and safety and hygiene. A score describes product quality, not personal safety. Hidden amounts in proprietary blends are not guessed. The catalog uses NIH's Dietary Supplement Label Database (200,000+ source labels), not laboratory measurements of every bottle. A small group, including clinicians, is testing the app before wider access. Core interaction analysis runs on-device, and medications, conditions and health profiles stay on the user's phone by default unless explicitly shared with an AI assistant; a signed-in user's supplement list is backed up to their account. FDA recall alerts are in development and are not available in the current beta. Founded in 2025 by Sean Cheick Baradji and B&Br Technology, headquartered in Boston, MA.
The founder story
It happened twice. Then he built the fix.
Sean Cheick Baradji built PharmaGuide after the same failure happened twice in his family. His father was hospitalized while on blood pressure medication and prescribed a new drug with a documented interaction with his existing prescription, a conflict a simple cross-reference could have highlighted. Later, after his own diagnosis and prescription, Cheick discovered by accident that a supplement he was taking was interfering with his medication. The information existed in both cases. Nobody had connected the dots, because prescriptions live in one system and supplements in another. A self-taught developer based in Boston, he built PharmaGuide to bring that information together. A small group, including clinicians, is testing the app as he works toward wider access. He also founded Keniya Health, a condition-aware snack box company. PharmaGuide beta access is opening in small groups.
“Nobody was reading my whole stack. The pharmacist saw the prescriptions, the label showed the supplement, and the interaction lived in the gap between them.”
“A supplement being on the shelf is not the same as FDA approval. People deserve a clearer way to understand the label, the evidence and what a warning means.”
“High-risk questions should never be an AI's freehand answer. Our core interaction checks use rules and reference data. The point is to explain what we know and make the limits clear, not replace clinical judgment.”
Team & clinical perspectives
Names + bios for attribution.
Sean Cheick Baradji
Founder & CEO
B&Br Technology · Boston, MA
Built PharmaGuide after watching family members navigate medication and supplement complexity without the tools to do it safely.
Laurie Pham, PharmD
Doctor of Pharmacy · Clinical Review
15+ years pharmacovigilance
Provides a pharmacy perspective on interaction explanations, pharmacovigilance and how warnings are presented during development and beta testing.
Miriam Farez, NP
Nurse Practitioner · Patient-Education Review
Integrative health practice
Provides a nurse practitioner's perspective on patient education, wording and accessibility during development and beta testing.
Brand assets
Logo, screenshots, brand colors.
Brand colors
- Accent · deep teal#183B3F
- Background · warm cream#FAF9F6
- Ink · near black#111314
- Surface · subtle#F4F2EE
Brand usage
How to write our name + a few rules.
PharmaGuide
One word, capital P + G. Camel-case.
Pharma Guide
Don't space it. ✕
PharmaGuide is a supplement and medication safety platform
Default first-mention sentence.
Use specific descriptions: "on-device stack checks," "product information," and "interaction warnings."
Avoid claims of clinical validation, complete coverage or guaranteed safety.
Story angles we can help with
Bring us a story. We will bring the data.
The gummy problem
A 2023 JAMA study found 22 of 25 tested melatonin gummies inaccurately labeled, including one with no detectable melatonin. We can explain the published findings and walk through a gummy label. Our catalog contains label information, not measurements of what is inside each bottle.
Read the JAMA studyMedication and nutrient links
How to read the evidence behind a medication and nutrient link, and what to ask a clinician about monitoring. We can explain why a biochemical change does not automatically establish a benefit from taking a supplement.
What proprietary blends hide
We can walk through examples of blend labels that disclose ingredients but not individual amounts, and explain why that limits dose-based conclusions. We do not guess hidden quantities.
FDA recall alerts, in development
Recall notices can be difficult to follow and match to the products people use. We are building FDA recall alerts to help with that gap. They are in development and are not available in the current beta.
FDA recall informationInterview topics: Sean Cheick Baradji (founder)
Building PharmaGuide as a self-taught solo founder; making supplement labels and warning explanations easier to understand; privacy boundaries; testing with small groups before wider access.
Interview topics: Laurie Pham, PharmD (clinical perspective)
Drug and supplement interactions clinicians worry about most; how to read a supplement label like a pharmacist; nutrient depletion from common prescriptions.
Couldn't find what you needed?
Email press@pharmaguide.io with your story angle, preferred interview time and deadline. We'll get back to you about availability.
Read more about us